- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06192251
Complete Lifestyle Medicine Intervention Program (CLIP)
Complete Lifestyle Medicine Intervention Program (CLIP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will have the option of a hybrid platform to ensure equal access. Participants will attend (virtually or in person) a weekly lecture on Lifestyle Medicine Pillars for 16 weeks followed by a weekly exercise program for 8 weeks. This program was inspired by the research team of Albert et al 2022.
The eligibility criteria for participation in the lifestyle medicine program include adults with chronic diseases such as
- prediabetes,
- type 2 diabetes,
- pre-hypertension,
- systemic hypertension,
- heart disease, dyslipidemia,
- and/or excess weight (BMI ≥ 25 (42)).
Patients will be invited through referral by their physicians, email by local heart disease and diabetes foundation, mail-out by nurse practitioner and community health teams. Metrics:
Participants will be evaluated using validated pre-and post intervention validated surveys provided by the American College of Lifestyle Medicine, The Lifestyle Assessment Short Form. Added to the validated survey included questions on demographic characteristics including gender, age, race and ethnicity, language use, education, health insurance marital status. Participants will complete The Well-being Assessment and Lifestyle Medicine Survey (American College of Lifestyle Medicine)
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Lisa Allen, PhD
- Phone Number: 7056622901
- Email: lisa.allen@mahc.ca
Study Locations
-
-
Ontario
-
Parry Sound, Ontario, Canada, P2A3A4
- Recruiting
- West Parry Sound Health Centre
-
Contact:
- Mylene Juneau, MN
- Phone Number: 705-746-9321
- Email: mylene@whole-health.ca
-
Principal Investigator:
- Mylene Juneau, MD
-
Sub-Investigator:
- Caroline Rheaume, MD
-
Sub-Investigator:
- Kush Patel, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- prediabetes,
- type 2 diabetes,
- pre-hypertension,
- systemic hypertension,
- heart disease, dyslipidemia,
- and/or excess weight (BMI ≥ 25 (42)).
Exclusion Criteria:
- Healthy participants
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cohort 1
Weekly classes of pillars of lifestyle medicine, monthly sessions with dietician, Lifestyle Medicine physician,kinesiologist and health coach
|
Education and support for lifestyle modification to improve health conditions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant Feedback
Time Frame: 1 month
|
Collect pre-and post intervention survey responses using the validated Lifestyle Medicine Scales (The Lifestyle Assessment Short Form) and The Well-being Assessment and Lifestyle Medicine Survey)
|
1 month
|
Participant Feedback
Time Frame: 1 month
|
Collect pre-and post intervention survey responses using the validated Lifestyle Medicine Scales (The Well-being Assessment Survey)
|
1 month
|
Participant Feedback
Time Frame: 1 month
|
Collect pre-and post intervention survey responses using the validated Lifestyle Medicine Scales (Lifestyle Medicine Survey)
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant Feedback
Time Frame: 6 months
|
Participants will be invited to participate in focus groups at the end of the 22 week intervention to share their opinions about the material covered, how the study could be improved and general feedback.
|
6 months
|
Collaborators and Investigators
Investigators
- Study Chair: Caroline Rheaume, MD, Laval
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLIP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
Abiomed Inc.RecruitingHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
Kathirvel SubramaniamUniversity of Maryland, Baltimore; CSL BehringRecruitingHeart Failure,Congestive | Heart Disease End StageUnited States
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Yonsei UniversityCompletedMitral Valvular Heart Disease
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Lifestyle Medicine
-
Chinese University of Hong KongUniversity of Melbourne; University of Western SydneyUnknown
-
Chinese University of Hong KongThe University of Hong Kong; The Hong Kong Polytechnic University; University... and other collaboratorsUnknown
-
Chinese University of Hong KongNot yet recruiting
-
Chinese University of Hong KongNot yet recruiting
-
Chinese University of Hong KongUnknown
-
Chinese University of Hong KongUnknown
-
Scripps Center for Integrative MedicineUnknown
-
Chinese University of Hong KongNot yet recruitingGeneralised Anxiety DisorderHong Kong
-
Ohio UniversityCompletedCardiovascular Diseases | Hypertension | Diabetes | Dyslipidemias | Overweight and Obesity | Chronic Lifestyle Related DiseaseUnited States
-
Chinese University of Hong KongUniversity of Melbourne; University of Western SydneyCompletedPsychological WellbeingHong Kong